Chronic allograft dysfunction: Diagnosis and management. Is it always progressive?

被引:15
作者
Neuberger, J [1 ]
机构
[1] Queen Elizabeth Hosp, Liver Unit, Birmingham B15 2TH, W Midlands, England
关键词
D O I
10.1002/lt.20603
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
1. There are many causes of graft dysfunction post-liver transplant, but recurrent disease remains the most common cause. 2. Viral hepatitis, nonalcoholic and alcoholic steatohepatitis, and autoimmune diseases are the most common causes of recurrent disease. 3. Graft hepatitis occurs frequently and in many cases will not progress. 4. Cirrhosis in the absence of any identifiable cause develops in a minority. 5. Treatment is of the underlying cause but some, such as recurrent and de novo autoimmune hepatitis and recurrent primary sclerosing cholangitis may not respond well, and regraft may be required.
引用
收藏
页码:S63 / S68
页数:6
相关论文
共 27 条
[1]   Glutathione S-transferase T1 mismatch constitutes a risk factor for De Novo immune hepatitis after liver transplantation [J].
Aguilera, I ;
Sousa, JM ;
Gavilán, F ;
Bernardos, A ;
Wichmann, I ;
Nuñez-Roldán, A .
LIVER TRANSPLANTATION, 2004, 10 (09) :1166-1172
[2]   Cryptogenic cirrhosis: Clinicopathologic findings at and after liver transplantation [J].
Ayata, G ;
Gordon, FD ;
Lewis, D ;
Pomfret, E ;
Pomposelli, JJ ;
Jenkins, RL ;
Khettry, U .
HUMAN PATHOLOGY, 2002, 33 (11) :1098-1104
[3]   Are posttransplantation protocol liver biopsies useful in the long term? [J].
Berenguer, M ;
Rayón, JM ;
Prieto, M ;
Aguilera, V ;
Nicolás, D ;
Ortiz, V ;
Carrasco, D ;
López-Andujar, R ;
Mir, J ;
Berenguer, J .
LIVER TRANSPLANTATION, 2001, 7 (09) :790-796
[4]   Distinct enzyme profiles in patients with cryptogenic cirrhosis reflect heterogeneous causes with different transplantation (OLT):: A long-term documentation before and after OLT [J].
Berg, T ;
Neuhaus, R ;
Klein, R ;
Leder, K ;
Lobeck, H ;
Beckstein, WO ;
Müller, AR ;
Wiedenmann, B ;
Hopf, U ;
Berg, PA ;
Neuhaus, P .
TRANSPLANTATION, 2002, 74 (06) :792-798
[5]  
Charlton M R, 1997, Liver Transpl Surg, V3, P359, DOI 10.1053/jlts.1997.v3.pm0009346764
[6]  
Charytan D, 2004, J NEPHROL, V17, P431
[7]   NODULAR REGENERATIVE HYPERPLASIA OF THE LIVER GRAFT AFTER LIVER-TRANSPLANTATION [J].
GANE, E ;
PORTMANN, B ;
SAXENA, R ;
WONG, P ;
RAMAGE, J ;
WILLIAMS, R .
HEPATOLOGY, 1994, 20 (01) :88-94
[8]   An evaluation of long-term outcomes after liver transplantation for cryptogenic cirrhosis [J].
Heneghan, MA ;
Zolfino, T ;
Muiesan, P ;
Portmann, BC ;
Rela, M ;
Heaton, ND ;
O'Grady, JG .
LIVER TRANSPLANTATION, 2003, 9 (09) :921-928
[9]   Graft dysfunction mimicking autoimmune hepatitis following liver transplantation in adults [J].
Heneghan, MA ;
Portmann, BC ;
Norris, SM ;
Williams, R ;
Muiesan, P ;
Rela, M ;
Heaton, ND ;
O'Grady, JG .
HEPATOLOGY, 2001, 34 (03) :464-470
[10]   Antibodies against cytokeratin 8/18 in a patient with de novo autoimmune hepatitis after living-donor liver transplantation [J].
Inui, A ;
Sogo, T ;
Komatsu, H ;
Miyakawa, H ;
Fujisawa, T .
LIVER TRANSPLANTATION, 2005, 11 (05) :504-507